natgillin/translations-raw huggingface dataset:
Furthermore, the overall risk of nocturnal hypoglycaemia in children and adolescents aged 6 to 17 years with type 1 diabetes was significantly lower with Levemir compared to NPH insulin.
Poleg tega je bilo celotno tveganje za nočno hipoglikemijo pri otrocih in mladostnikih starih od 6 do 17 let s sladkorno boleznijo tipa 1 bistveno nižje pri zdravljenju z zdravilom Levemir v primerjavi z insulinom NPH.
Antibody development has been observed with the use of Levemir.
Med uporabo insulina Levemir so opažali pojav protiteles.
Within-patient variation in absorption is lower for Levemir than for other basal insulin preparations.
18 Razlike v absorpciji med bolniki so pri zdravljenju z zdravilom Levemir manjše kot pri drugih pripravkih bazalnega insulina.
There are no clinically relevant differences between genders in pharmacokinetic properties of insulin detemir.
Farmakokinetične lastnosti zdravila Levemir se med spoloma klinično pomembno ne razlikujejo.
The pharmacokinetic properties of insulin detemir were investigated in children (6– 12 years) and adolescents (13– 17 years) and compared to adults with type 1 diabetes.
Farmakokinetične lastnosti insulina detemir, določene pri otrocih (6– 12 let) in mladostnikih (13 – 17 let), so bile primerjane z lastnostmi pri odraslih bolnikih s sladkorno boleznijo tipa1.
19 Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction.
Neklinični podatki na podlagi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih, genotoksičnosti in vpliva na sposobnost razmnoževanja ne kažejo posebnega tveganja za ljudi.
Glycerol Phenol Metacresol Zinc acetate Disodium phosphate dihydrate Sodium chloride Hydrochloric acid 2N (pH adjustment) Sodium hydroxide 2N (pH adjustment) Water for injections
19 klorovodikova kislina 2N (za uravnavanje pH) natrijev hidroksid 2N (za uravnavanje pH) voda za injekcije
After first opening the product must be stored for a maximum of 6 weeks, not above 30°C.
Po prvem odprtju je dovoljeno zdravilo shranjevati največ 6 tednov pri temperaturi do 30°C.
Keep the pen cap on when Levemir FlexPen is not in use in order to protect from light.
Kadar peresnika Levemir FlexPen ne uporabljate, naj bo vedno pokrit s pokrovčkom, da bo zaščiten pred svetlobo.
Do not store above 30ºC.
Med uporabo: ne shranjujte v hladilniku ali pri temperaturi nad 30 °C!
3 ml solution in a cartridge (type 1 glass) with a plunger (bromobutyl) and a stopper (bromobutyl/ polyisoprene) contained in a pre-filled pen (multidose disposable pen) (polypropylene).
3 ml raztopina v injekcijskem vložku (steklo tipa I) z batom (brombutil) in zamaškom (brombutil/ poliizopren) v napolnjenem injekcijskem peresniku (večodmerni peresnik, ki se zavrže) (polipropilen).
Pack size of 1, 5 and 10 pre-filled pens.
Velikost pakiranja po 1, 5 in 10 napolnjenih injekcijskih peresnikov.
Levemir should not be used if it does not appear clear and colourless.
Zdravila Levemir ne smete uporabiti, če raztopina ni bistra in brezbarvna.
20 The patient should be advised to discard the needle after each injection.
Bolnika opozorite, naj po vsakem injiciranju iglo zavrže.
EU/ 1/ 04/ 278/ 004 EU/ 1/ 04/ 278/ 005 EU/ 1/ 04/ 278/ 006
20 EU/ 1/ 04/ 278/ 004 EU/ 1/ 04/ 278/ 005 EU/ 1/ 04/ 278/ 006
InnoLet
Raztopina za injiciranje v napolnjenem injekcijskem peresniku Innolet.
Levemir is a long-acting insulin analogue used as a basal insulin.
Levemir je dolgodelujoč analog insulina, ki se lahko uporablja kot bazalni insulin.
22 For patients who require twice daily dosing to optimise blood glucose control, the evening dose can be administered in the evening or at bedtime.
22 Bolnikom, ki zaradi boljšega uravnavanja glukoze v krvi potrebujejo odmerjanje dvakrat dnevno, je mogoče večerni odmerek aplicirati zvečer ali pred spanjem.
Levemir InnoLet is accompanied by a package leaflet with detailed instruction for use to be followed.
Levemir InnoLet ima priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
23 Concomitant illness, especially infections and feverish conditions, usually increases the patient's insulin requirement.
23 Spremljajoče bolezni, posebno okužbe in stanja z zvišano telesno temperaturo, ponavadi zvečajo bolnikovo potrebo po insulinu.
24 Animal reproduction studies have not revealed any differences between insulin detemir and human insulin regarding embryotoxicity and teratogenicity.
Reprodukcijske raziskave pri živalih niso pokazale razlik v embriotoksičnosti ali teratogenosti med insulinom detemir in humanim insulinom.
In general, intensified blood glucose control and monitoring of pregnant women with diabetes are recommended throughout pregnancy and when contemplating pregnancy.
24 Na splošno sta pri ženskah s sladkorno boleznijo med celotno nosečnostjo in pred nameravano nosečnostjo priporočljiva intenzivnejša kontrola glukoze v krvi in spremljanje nosečnice.
From clinical investigations it is known that major hypoglycaemia, defined as requirement for third party interventions, occurs in approximately 6% of the patients treated with Levemir.
Iz kliničnih raziskav je znano, da se hude hipoglikemije – opredeljene kot takšne, pri katerih je nujno posredovanje nekoga drugega – pojavijo pri približno 6% bolnikov, zdravljenih z zdravilom Levemir.
Most of the injection site reactions are minor and of a transitory nature, i. e. they normally disappear during continued treatment in a few days to a few weeks.
Večina reakcij na mestu injiciranja je blagih ini prehodnih, tj. med nadaljevanjem zdravljenja običajno izginejo v nekaj dneh do nekaj tednih.
Severe
Obsegajo lahko hladno znojenje, hladno bledo kožo, utrujenost, živčnost ali tremor, tesnobnost, nenavadno izčrpanost ali šibkost, zmedenost, težave s koncentracijo, zaspanost, čezmerno lakoto, motnje vida, glavobol, slabost in palpitacije.
Injection site reactions (redness, swelling and itching at the injection site) may occur during treatment with insulin.
25 reakcije na mestu injiciranja (pordelost, oteklina in srbenje na mestu injiciranja).
• Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.
26 • Blage hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali sladkih izdelkov.
27 The blood glucose lowering effect of insulin detemir is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.
Insulin detemir znižuje glukozo v krvi tako, da olajša njen privzem po vezavi insulina na receptorje na mišičnih in maščobnih celicah in hkrati zavre sproščanje glukoze iz jeter.
Pharmacodynamic Parameters for Levemir and NPH Glucose infusion rate (mg/ kg/ min)
27 F a r m a k o d i n a m ič n i p a r a m e t r i z a L e v e m i r i n N P H
U/ kg U/ kg U/ kg
v e m ir
In long-term treatment trials in patients with type 1 diabetes, fasting plasma glucose was improved with Levemir compared with NPH insulin when given as basal/ bolus therapy including in children and adolescents aged 6 to 17 years.
V preskušanjih z dolgotrajnim zdravljenjem pri bolnikih z diabetesom tipa I se je stanje plazemske glukoze na tešče ob bazalnem/ bolusnem zdravljenju z zdravilom Levemir v primerjavi z insulinom NPH izboljšalo, in sicer tudi pri otrocih in mladostnikih starih od 6 do 17 let.
28 In clinical trials using basal bolus insulin therapy, the overall rates of hypoglycaemia with Levemir and NPH insulin were similar.
28 Klinična preskušanja, v katerih so uporabljali bazalno- bolusno zdravljenje z insulinom, so pokazala, da je celotna pogostost pojava hipoglikemije podobna pri zdravljenju z zdravilom Levemir ali insulinom NPH.
Analyses of nocturnal hypoglycaemia in patients with type 1 diabetes showed a significantly lower risk of minor nocturnal hypoglycaemia (able to self-treat and confirmed by capillary blood glucose less than 2.8 mmol/ L or 3.1 mmol/ L if expressed as plasma glucose) than with NPH insulin, whereas no difference was seen in type 2 diabetes.
Analize nočne hipoglikemije pri bolnikih s sladkorno boleznijo tipa 1 so pokazale bistveno nižje tveganje za blago nočno hipoglikemijo (kadar ni potrebno dodatno zdravljenje in je glukoza v kapilarni krvi nižja od 2, 8 mmol/ l ali 3, 1 mmol/ l, če je izražena kot plazemska glukoza) kot pri insulinu NPH, pri diabetesu tipa 2 pa ta razlika ni opazna.
The pharmacokinetic properties of insulin detemir were investigated in children (6– 12 years) and adolescents (13– 17 years) and compared to adults with type 1 diabetes.
Farmakokinetične lastnosti zdravila Levemir, določene pri otrocih (6– 12 let) in mladostnikih (13 – 17 let), so bile primerjane z lastnostmi pri odraslih bolnikih s sladkorno boleznijo tipa 1.
As the pharmacokinetics of insulin detemir has not been studied extensively in these populations, it is
Zaželeno je nadziranje glukoze v
29 advised to monitor plasma glucose closely in these populations.
29 plazmi, saj študije farmakokinetike insulina detemir pri teh bolnikih še niso opravljene.
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction.
Neklinični podatki na podlagi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih, genotoksičnosti in vpliva na sposobnost razmnoževanja ne kažejo posebnega tveganja za ljudi.
Store in a refrigerator (2°C - 8°C) not near a freezing compartment.
Shranjujte v hladilniku (pri temperaturi med 2 °C in 8°C), ne v bližini zamrzovalnega razdelka!
Keep the pen cap on when Levemir InnoLet is not in use in order to protect from light.
Kadar peresnika Levemir InnoLet ne uporabljate, naj bo vedno pokrit s pokrovčkom, da bo zaščiten pred svetlobo.
6.6 Special precautions for disposal and other handling
30 6. 6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom
30 Levemir should not be used if it does not appear clear and colourless.
Zdravila Levemir ne smete uporabiti, če raztopina ni bistra in brezbarvna.
32 A MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
IZDELOVALEC BIOLOŠKE ZDRAVILNE UČINKOVINE IN IMETNIK DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVOREN ZA SPROŠČANJE SERIJE
35 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ANDTHE IMMEDIATE PACKAGING
35 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Levemir 100 U/ ml solution for injection in a cartridge Insulin detemir
Levemir 100 e. / ml raztopina za injiciranje v injekcijskem vložku insulin detemir
1 ml contains 100 U (14.2 mg) of insulin detemir, rDNA,
(14, 2 mg) insulina detemir, rDNA,
glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections
glicerol, fenol, metakrezol, cinkov acetat, natrijev hidrogenfosfat dihidrat, natrijev klorid, klorovodikovo kislino, natrijev hidroksid in vodo za injekcije.
Penfill.
raztopina za injiciranje v injekcijskem vložku Penfill 1 x 3 ml
Subcutaneous use Levemir Penfill cartridges for use with Novo Nordisk insulin devices Levemir Penfill is for use by one person only Read the package leaflet before use
Levemir Penfill je namenjen uporabi ene same osebe.
EXP/ During use: use within 6 weeks
Med uporabo: porabite v 6 tednih!
Store in a refrigerator (2°C - 8°C) Do not freeze Keep the cartridge in the outer carton During use:
Injekcijski vložek shranjujte v zunanji ovojnini!
Do not refrigerate or store above 30°C
Med uporabo: ne shranjujte v hladilniku ali pri temperaturi nad 30 °C!
37 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
37 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
5 x 3 ml
raztopina za injiciranje v injekcijskem vložku Penfill 5 x 3 ml
39 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
39 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
10 x 3 ml
raztopina za injiciranje v injekcijskem vložku Penfill 10 x 3 ml
Store in a refrigerator (2°C - 8°C) Do not freeze Keep the cartridge in the outer carton During use:
40 Injekcijski vložek shranjujte v zunanji ovojnini!
Levemir 100 U/ ml solution for injection in a cartridge Insulin detemir SC use
Levemir 100 e. / ml raztopina za injiciranje v injekcijskem vložku insulin detemir
EXP/
Uporabno do:
42 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
42 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
Levemir 100 U/ ml solution for injection in a pre-filled pen Insulin detemir
Levemir 100 i. e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin detemir
FlexPen
raztopina za injiciranje v napolnjenem injekcijskem peresniku FlexPen 1 x 3 ml
Subcutaneous use Designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm Needles are not included.
Namenjen je za uporabo z iglami NovoFine ali NovoTwist za enkratno uporabo, dolžine do 8 mm.
Levemir FlexPen is for use by one person only Read the package leaflet before use
Levemir FlexPen je namenjen uporabi ene same osebe.
Store in a refrigerator (2°C - 8°C) Do not freeze Keep the pen cap on in order to protect from light During use:
Peresnik naj bo pokrit s pokrovčkom, da ga zaščitite pred svetlobo!
44 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
44 PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI
FlexPen
raztopina za injiciranje v napolnjenem injekcijskem peresniku FlexPen
Subcutaneous use Designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mmNeedles are not included Levemir FlexPen is for use by one person only Read the package leaflet before use
Pred uporabo preberite priloženo navodilo!
46 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
46 PODATKI NA ZUNANJI OVOJNINI INPRIMARNI OVOJNINI
10 x 3 ml
5 x 3 ml
Levemir 100 U/ ml solution for injection in a pre-filled pen Insulin detemir SC use
Levemir 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin detemir
49 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
49 PODATKI NA ZUNANJI OVOJNINI INPRIMARNI OVOJNINI
InnoLet
raztopina za injiciranje v napolnjenem injekcijskem peresniku InnoLet
Subcutaneous use Levemir InnoLet is especially designed to be used with NovoFine S needles.
Levemir InnoLet je namenjen za uporabo z iglami NovoFine S.
NovoFine needles are not included.
Igle NovoFine niso priložene.
Levemir InnoLet is for use by one person only Read the package leaflet before use
Pred uporabo preberite priloženo navodilo!
51 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING
51 PODATKI NA ZUNANJI OVOJNINI INPRIMARNI OVOJNINI
InnoLet
raztopina za injiciranje v napolnjenem injekcijskem peresniku Innolet
55 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
55 PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Levemir 100 U/ ml solution for injection in a pre-filled pen Insulin detemir Sc use
Levemir 100 e. / ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin detemir
InnoLet
Innolet
Levemir 100 U/ ml solution for injection in a cartridge Penfill insulin detemir
Levemir 100 e. / ml raztopina za injiciranje v injekcijskem vložku Penfill insulin detemir
Read all of this leaflet carefully before you start using this medicine. – Keep this leaflet.
Preden začnete uporabljati vaš insulin, natančno preberite navodilo. – Navodilo shranite.
Do not pass it on to others.
Morda ga boste želeli ponovno prebrati. – Če imate dodatna vprašanja, se posvetujte z zdravnikom, diabetološko sestro ali farmacevtom. – Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
WHAT LEVEMIR IS AND WHAT IT IS USED FOR
KAJ JE ZDRAVILO LEVEMIR IN ZA KAJ GA UPORABLJAMO
Levemir is a human insulin analogue to treat diabetes.
Levemir je analog humanega insulina za zdravljenje diabetesa.
It comes in a 3 ml cartridge, called Penfill, which fits into an insulin delivery system.
Na voljo je v 3- ml vložkih, imenovanih Penfill, ki se jih vstavi v sistem za dajanje insulina.
Levemir is a long-acting human insulin analogue lowering your blood glucose.
Levemir je dolgodelujoč analog humanega insulina za zniževanje glukoze v krvi.
The effect will last for up to 24 hours depending on dose.
Učinek je odvisen od odmerka in traja do 24 ur.
It may be used in combination with oral antidiabetic agents or with meal-related short- or rapid acting insulins.
Uporabljati ga je mogoče v kombinaciji s peroralnimi antidiabetiki ali s kratkodelujočimi oz. hitrodelujočimi insulini, danimi ob obrokih.
BEFORE YOU USE LEVEMIR
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO LEVEMIR
Do not use Levemir
Ne uporabljajte zdravila Levemir:
► If you are allergic (hypersensitive) to insulin detemir, metacresol or any of the other ingredients (see 7 Further information).
če ste alergični na (preobčutljivi za) insulin detemir, metakrezol ali katero drugo pomožno ► snov (glejte poglavje 7.
Look out for the signs of allergy in 5 Possible side effects ► If you feel a hypo coming on (a hypo is short for a hypoglycaemic reaction and is symptoms of low blood sugar).
Možni neželeni učinki. če čutite, da se pojavlja hipa (hipa je okrajšava za hipoglikemično reakcijo in pomeni ► simptome nizkega sladkorja v krvi).
Take special care with Levemir
Pri uporabi zdravila Levemir bodite posebej pozorni:
► If you have trouble with your kidneys or liver, or with your adrenal, pituitary or thyroid glands ► If you are drinking alcohol: watch for signs of a hypo ► If you are exercising more than usual or if you want to change your usual diet ► If you are ill: carry on taking your insulin ► If you are going abroad: travelling over time zones may affect your insulin needs
če imate težave z ledvicami, jetri, nadledvično žlezo, hipofizo ali ščitnico. ► če pijete alkohol: pazite na znake hipe. ► če ste telesno bolj dejavni kot ponavadi ali želite spremeniti svojo običajno prehrano. ► če ste bolni: insulin uporabljajte še naprej. ► če potujete v tujino: potovanje med različnimi časovnimi pasovi lahko vpliva na potrebe po ► insulinu.
Pregnancy and breast-feeding ► If you are pregnant, planning a pregnancy or breast-feeding please contact your doctor for advice.
Nosečnost in dojenje če ste noseči, nameravate zanositi ali dojite, se posvetujte s svojim zdravnikom. ►
Driving and using machines ► If you drive or use tools or machines: watch out for signs of a hypo.
Vpliv na sposobnost upravljanja vozil in strojev če vozite ali uporabljate orodja ali stroje: pazite na znake hipe.
Your ability to concentrate or to react will be less during a hypo.
Vaša sposobnost za ► koncentracijo ali reagiranje se med hipo zmanjša.
Discuss with your doctor whether you should drive or use machines at all, if you have a lot of hypos or if you find it hard to recognise hypos.
Z zdravnikom se posvetujte, ali sploh lahko vozite ali upravljate s stroji, če doživljate veliko hip ali hipe težko prepoznate.
There is no clinical experience with Levemir in children below the age of 6 years.
Pri otrocih, mlajših od 6 let, ni kliničnih izkušenj z zdravilom Levemir.
58 Using other medicines
58 Številna zdravila vplivajo na delovanje glukoze v telesu in lahko tako vplivajo na vaš odmerek insulina.
Listed below are the most common medicines, which may affect your insulin treatment.
Spodaj so našteta najpogostejša zdravila, ki lahko vplivajo na vaše zdravljenje z insulinom.
Talk to your doctor or pharmacist if you take or change any other medicines, even those not prescribed.
Posvetujte se z zdravnikom ali farmacevtom, če jemljete ali zamenjate katera koli druga zdravila, tudi takšna, ki niso na recept.
Your need for insulin may change if you also take: oral antidiabetic medicinal products; monoamine oxidase inhibitors (MAOI); beta-blockers; ACE-inhibitors; acetylsalicylic acid; thiazides; glucocorticoids; thyroid hormone therapy; beta-sympathomimetics; growth hormone; danazol; octreotide and lanreotide.
Vaša potreba po insulinu se lahko spremeni, če uporabljate tudi: peroralne antidiabetike, zaviralce monoaminooksidaze (MAOI), zaviralce beta, zaviralce ACE, acetilsalicilno kislino, tiazide, glukokortikoide, zdravljenje s ščitničnimi hormoni, beta- simpatikomimetike, rastni hormon, danazol, oktreotid in lanreotid.
HOW TO USE LEVEMIR
KAKO UPORABLJATI ZDRAVILO LEVEMIR
Before using Levemir
Preden uporabite zdravilo Levemir:
► Check the label to make sure it is the right type of insulin ► Always check the cartridge, including the rubber plunger (stopper).
preverite nalepko, da se boste prepričali, ali imate pravo vrsto insulina. ► vedno preverite vložek, vključno z gumijastim batom (zamaškom).
See your delivery system manual for further instructions ► Disinfect the rubber membrane with a medicinal swab ► Always use a new needle for each injection to prevent contamination.
Za nadaljna navodila glejte priročnik za uporabo svojega sistema za dajanje insulina. dezinficirajte gumijasto membrano z medicinskim zložencem. ► za vsako injiciranje vedno uporabite novo iglo, da preprečite kontaminacijo. ►
Levemir must not be used
Zdravila Levemir ne uporabljajte:
► In insulin infusion pumps ► If the cartridge or the device containing the cartridge is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn ’ t been stored correctly or if it has been frozen (see 6 How to store Levemir) ► If the insulin does not appear water clear and colourless.
Shranjevanje zdravila Levemir). ► če insulin ni bister in brezbarven. ►
Do not refill the cartridge.
Vložkov se ne sme znova polniti.
Levemir Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine needles.
Injekcijski vložki Levemir Penfill so namenjeni za uporabo s sistemi za dajanje insulina Novo Nordisk in iglami NovoFine.
If you are treated with Levemir Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin.
Če se zdravite z zdravilom Levemir Penfill in še drugim insulinom v vložkih Penfill, morate uporabljati dva sistema za dajanje insulina, enega za vsako vrsto insulina.
Levemir is for injection under the skin (subcutaneously).
Levemir je namenjen injiciranju pod kožo (subkutani uporabi).
Always vary the sites you inject within the same region, to avoid lumps (see 5 Possible side effects).
Mesta injiciranj v posameznem področju vedno menjajte, da boste preprečili nastanek zatrdlin (glejte poglavje 5.
The best places to give yourself an injection are: the front of your thighs; the front of your waist (abdomen), or the upper arm.
Najprimernejša mesta za injiciranje so: sprednji del stegen, sprednji del trebuha ali nadlakti.
You should always measure your blood glucose regularly.
Vedno si morate redno meriti sladkor v krvi.
How to inject this insulin
Injiciranje tega insulina
• Inject the insulin under the skin.
Insulin injicirajte pod kožo.
Use the injection technique advised by your doctor or diabetes nurse and described in your delivery system manual • Keep the needle under your skin for at least 6 seconds to make sure that the full dose has been delivered • After each injection be sure to remove and discard the needle and store Levemir without the needle attached.
Igla mora ostati pod kožo vsaj 6 sekund, da je zanesljivo vbrizgan celotni odmerek. • Po vsakem injiciranju morate iglo odstraniti in zavreči, Levemir pa shraniti brez nameščene • igle.
Otherwise, the liquid may leak out, which can cause inaccurate dosing.
V nasprotnem primeru lahko tekočina izteka, to pa lahko povzroči netočno odmerjanje.
If you get a hypo
59 Če doživite hipo
This may happen: • If you take too much insulin • If you eat too little or miss a meal • If you exercise more than usual.
To se lahko zgodi, če: • uporabite preveč insulina, • premalo jeste ali izpustite obrok, • ste telesno bolj dejavni kot ponavadi.
If you feel a hypo coming on: take a high sugar snack and then measure your blood sugar.
Če čutite, da se pojavlja hipa: zaužijte prigrizek, ki vsebuje veliko sladkorja in si nato izmerite sladkor v krvi.
Always carry glucose tablets, sweets, biscuits or fruit juice with you, just in case.
Za vsak primer vedno imejte pri sebi tablete glukoze, bonbone, piškote ali sadni sok.